Advertisement

Topics

A Penny Saved: Why Delaying 340B Pricing Rule Is Good News For Companies Like Horizon

12:22 EDT 24 Aug 2017 | SCRIP

HRSA proposes another delay to effective date of final rule on calculating the ceiling prices for drugs sold to 340B...

      

Related Stories

 

Original Article: A Penny Saved: Why Delaying 340B Pricing Rule Is Good News For Companies Like Horizon

NEXT ARTICLE

More From BioPortfolio on "A Penny Saved: Why Delaying 340B Pricing Rule Is Good News For Companies Like Horizon"

Advertisement
Quick Search
Advertisement
Advertisement